Blood and Cystic Fluid From Patients Undergoing Surgery for Worrisome Pancreatic Cysts

Translational Genomics Research Institute30 enrolled

Overview

The goal of this study is to collect biospecimens (blood and cystic fluid) and data from participants who have a pancreatic cyst that requires surgical resection. The blood and fluid samples will be analyzed for research into DNA, RNA, and proteins.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Pancreatic Cyst

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Voluntarily agree to participate by giving written informed consent prior to any study-specific procedures. * Subject at least 18 years of age and able to provide consent. Subject is willing and able to comply with requirements of the protocol. * Radiologically documented cyst of the pancreas for which surgical removal is clinically indicated. * Patient will be undergoing a surgical resection of their pancreatic cystic neoplasm. Exclusion Criteria: * Patient who is pregnant at the time of study enrollment and sample collection. * Patient will not be undergoing clinically indicated surgery for a pancreatic cystic neoplasm. * Patient is unwilling or unable to provide informed consent or comply with study procedures.

Locations (2)

Hoag Family Cancer Institute

Newport Beach, California, United States

RECRUITING

Piedmont HealthCare

Atlanta, Georgia, United States

RECRUITING

Outcomes

Primary Outcomes

Characterize the miRNA and protein signatures in exosomes derived from blood and cyst fluids in patients with worrisome cystic pancreatic tumors

Time frame: At enrollment

Central Contacts

Michael Demeure, MD

CONTACT

949-764-4577 clinicalresearch@hoag.org

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.